Letter to the Editor: Commentary on “Avoiding the Hazards of Ultraviolet Light in the Adolescent Population”

Main Article Content

Elise M Weisert
University of Texas Medical Branch

Ethan D Hinds III
University of Texas Medical Branch

Keywords

visible light, blue light, skincare, photoaging

Abstract

Abstract not available.

References

1. Auchus A, Brodell RT, Nahar VK, Ward KH. Avoiding the Hazards of Ultraviolet Light in the Adolescent Population. SKIN The Journal of Cutaneous Medicine. 2020;4(3):189-199.

2. Duteil L, Cardot‐Leccia N, Queille‐Roussel C, et al. Differences in visible light‐induced pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure. Pigment cell & melanoma research. 2014;27(5):822-826.

3. Liebel F, Kaur S, Ruvolo E, Kollias N, Southall MD. Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes. Journal of Investigative Dermatology. 2012;132(7):1901-1907.

4. Arjmandi N, Mortazavi G, Zarei S, Faraz M, Mortazavi S. Can Light Emitted from Smartphone Screens and Taking Selfies Cause Premature Aging and Wrinkles? Journal of Biomedical Physics & Engineering. 2018;8(4):447.

5. Shechter A, Kim EW, St-Onge M-P, Westwood AJ. Blocking nocturnal blue light for insomnia: A randomized controlled trial. Journal of psychiatric research. 2018;96:196-202.

6. Freitas JV, Junqueira HC, Martins WK, Baptista MS, Gaspar LR. Antioxidant role on the protection of melanocytes against visible light-induced photodamage. Free Radical Biology and Medicine. 2019;131:399-407.

Article Sidebar

PDF
Published
Aug 26, 2020
DOI https://doi.org/10.25251/skin.4.5.23

Article Details

How to Cite
Weisert, E. M., & Hinds III, E. D. (2020). Letter to the Editor: Commentary on “Avoiding the Hazards of Ultraviolet Light in the Adolescent Population”. SKIN The Journal of Cutaneous Medicine, 4(5), 486–487. https://doi.org/10.25251/skin.4.5.23
Issue
Vol. 4 No. 5 (2020): September Issue & Poster Presentations (FCPANP20® Dermatology Conference)
Section
Commentary & Notes
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.